Option Care 被选定为接受家庭肠内营养治疗的 Medicare 患者提供服务
By: Option Care
June 7, 2016
BANNOCKBURN, Ill., June 2, 2016 — Option Care Enterprises, Inc., a leading national provider of home and alternate treatment site infusion therapy, has been selected by the Centers for Medicare & Medicaid Services (CMS) to continue to provide home enteral (tube feeding) nutrition services to Medicare patients across the country.
通过竞争性投标过程，CMS 与符合特定质量和财务标准的 Medicare 供应商签订合同。自 2011 年启动 CMS 竞争性招标项目以来，Option Care 为 Medicare 患者提供了家庭肠内营养。
“CMS 继续选择了我们，表明 Option Care 是一个理想的合作伙伴，因为我们在提供优质护理方面的良好业绩记录能够确保成功的疗效，” Option Care 首席运营官 John Rademacher 说道。“我们患者的高满意度和高安全率证明我们将患者放在了我们个性化、体恤性护理方法的中心。”
2011 年，CMS 竞争性招标项目在首批 9 个大都会地区启动，自 7 月 1 日开始，将会包括 117 个区域。这是国会通过《2003 年 Medicare 处方药改善及现代化法案》授权的项目的一部分。某些耐用医疗设备、假肢、矫正器和用品 (DMEPOS) 的竞争性招标项目旨在减少患者的自费开支，并确保他们得到优质服务。它还旨在节省 Medicare 医疗保险的成本。
Option Care 的营养支持团队包括全美范围内的 1,800 多名临床医生和 100 名营养师，其领导团队在提供家庭营养治疗方面有合计超过 125 年的经验。Option Care 经由早期干预家庭管道喂食项目，通过帮助消除财务障碍、实施个性化的营养评估，以及在治疗开始前向患者提供教育，来弥补护理的潜在缺口。
Option Care 为营养健康受到各种急性和慢病疾病负面影响的患者提供家庭肠内营养支持以及家庭肠外（静脉注射）营养支持。这些疾病包括中风、癌症和胃肠道疾病等。
在提供家庭输液治疗方面，Option Care 的服务和高标准已被证明可预防住院并降低成本。2016 年一份 Option Care 研究发现，针对 126 名家庭肠内和 124 名家庭肠外患者的密切监测和前瞻性管理促成的干预措施最终避免了 957 天的住院天数，从而节省了 190 多万美元。这些干预措施包括管理高血糖或电解质失衡、预防脱水以及消除或减少腹泻。
Option Care 致力于向需要输液治疗的成年和儿童患者提供最高品质的家庭医疗保健护理服务，以医治各式复杂和严重的病症。除了提供家庭营养服务之外，Option Care 还提供家庭输液来治疗从传染病、癌症，到原发性免疫缺陷、自身免疫性疾病和晚期器官衰竭等各种疾病。
关于 Option Care
Option Care Enterprises, Inc. (Option Care) is one of the nation’s largest and most trusted providers of home and alternate treatment site infusion services. An industry leader, the company draws on nearly 40 years of clinical care experience to offer patient-centered therapy management. Option Care’s signature Home Infusion Plus services include the clinical management of infusion medicines, nursing support and care coordination. Option Care’s multidisciplinary team of more than 1,800 clinicians — including pharmacists, nurses and dietitians — are able to provide home infusion service coverage for nearly all patients across the United States needing treatment for complex and chronic conditions. Learn more at www.OptionCare.com.
# # #
You might also be interested in:
Regence and Option Care Health Partner to Provide Options for High-Risk Patients Who Rely on Infusion Therapy
Ensuring Patient Safety and Continuity of Care is Key During COVID-19 Public Health Crisis as Hospitals Face Unprecedented Challenges BANNOCKBURN, Ill., April 22, 2020 – Regence and Option Care Health, Inc. (“Option Care Health”) (NASDAQ: OPCH) today announced an expanded partnership to ease access to care and provide additional options for high-risk patients who rely on […]
Option Care 数据的新研究表明，接受正性肌力药物治疗家庭输液的心力衰竭患者在结合指导方针导向药物治疗的情况下，生存率有所提高
BANNOCKBURN, Ill., May 16, 2018 — Survival may improve when advanced heart failure patients receiving home infusion of inotropic therapy are also receiving guideline-directed care, suggest results of a large study recently published in The Journal of Heart and Lung Transplantation. The study was conducted by investigators from Keck School of Medicine of USC and Option […]